Search Results
Jun 09, 2026, 21:00 ET Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China
commercial asset, XPOVIO® (selinexor), is approved in the Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia, and has been included in the national insurance schemes in five of these
More news about: Antengene Corporation Limited
Jun 07, 2026, 20:00 ET Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
Asia Pacific markets. Its lead commercial asset, XPOVIO® (selinexor), is approved in the Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia, and has been included in the national insurance schemes in five of these
More news about: Antengene Corporation Limited
Jun 04, 2026, 09:00 ET K25.ai Secures US$6 Million Strategic Investment from Nasdaq-Listed NewGen at US$100 Million Valuation; Co-Founders to Join Board and Lead Digital Asset Treasury Strategy
extraction, outcome monitoring and resolution workflows.K25.ai is not offered to U.S. persons or to users located in Mainland China, Hong Kong, Macau or other restricted jurisdictions.ContactsK25.ai Media Contact
More news about: K25.ai
Jun 03, 2026, 06:00 ET ElpasBio Completes Patient Enrollment in Phase III Pivotal Clinical Trial of AlloJoin®
AlloJoin® for the treatment of KOA in Mainland China, Hong Kong SAR and Macau SAR. ElpasBio will continue to be responsible for the development, regulatory registration, and manufacturing of AlloJoin® in Mainland China, Hong Kong SAR, and Macau SAR, and will retain all commercialization rights outside these
More news about: ElpasBio Holdings
Jun 03, 2026, 00:00 ET Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026
Asia Pacific markets. Its lead commercial asset, XPOVIO® (selinexor), is approved in the Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia, and has been included in the national insurance schemes in five of these
More news about: Antengene Corporation Limited
Jun 02, 2026, 07:02 ET Diretor de marketing da KuCoin diz na BEYOND Expo que "a confiança está se tornando a nova infraestrutura" para a Web3
MACAU, 2 de junho de 2026 /PRNewswire/ -- À medida que o setor de criptoativos deixa para trás ciclos de crescimento especulativo, a KuCoin avalia que a próxima fase da competição na Web3 será definida não por tráfego ou incentivos
More news about: KuCoin
Jun 01, 2026, 05:50 ET Haisco Announces Licensing and Research Collaboration Agreement with Lilly to Develop Innovative Medicines Across Multiple Therapeutic Areas
development, and commercialization. Lilly will obtain exclusive worldwide rights to certain programs, and exclusive rights outside mainland China, Hong Kong, Macau, and Taiwan (the "Haisco Territory") for certain other programs, while Haisco will retain rights within the Haisco Territory for those programs."This
More news about: Haisco Pharmaceutical Group Co., Ltd.
May 29, 2026, 09:08 ET Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions
Alfa (a next-generation human-derived ultra-long-acting GLP-1 receptor agonist), is approved for type 2 diabetes in Chinese Mainland and Macau SAR, included in China's National Reimbursement Drug List, and is under global development and registration. Learn more:
More news about: Innogen Pharmaceuticals
May 28, 2026, 06:05 ET Lenovo and Frore Systems collaborate to bring Future Innovation to market with AirJet®Mini
will be appearing in Lenovo products following collaboration with Lenovo's Innovation AcceleratorMACAU, May 28, 2026 /PRNewswire/ -- Frore Systems, today announced their collaboration with Lenovo's Innovation Accelerator
More news about: Frore Systems, Inc.
May 27, 2026, 20:00 ET Antengene Receives CDE Endorsement to Initiate Pivotal Phase III CLINCH-3 Study of ATG-022 in CLDN18.2+ Advanced Gastric/GEJ Cancer
Asia Pacific markets. Its lead commercial asset, XPOVIO® (selinexor), is approved in the Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia, and has been included in the national insurance schemes in five of these
More news about: Antengene Corporation Limited
May 27, 2026, 02:05 ET CGBIO、NOVOSISの米国・カナダ・オーストラリアにおけるグローバル臨床開発および独占商業化契約を締結
Synthesは米国、カナダ、およびオーストラリアにおけるNOVOSIS製品群の独占商業化権を取得する。また、両社は米国食品医薬品局（FDA）の治験機器適用免除（IDE）および市販前承認（PMA）を含むグローバル臨床開発および規制承認プロセスを共同で推進する。CGBIOはこれに先立ち、2025年にJohnson & JohnsonとNOVOSISに関する韓国、Taiwan Region、タイ、インド、Hong Kong SAR、Macau SAR地域での独占販売およびプロモーション契約を締結し、その後マレーシアおよびシンガポールへも提携範囲を拡大していた。今回の新たな契約により、協業範囲は北米およびオーストラリアへと拡大され、アジア太平洋地域を超えたグローバル市場展開の基盤がさらに強化される。両社は共同でステアリングコミッティ（Steering
More news about: CGBIO
May 22, 2026, 16:06 ET AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
0.51 %Macau
More news about: AllianceBernstein Global High Income Fund, Inc.
May 21, 2026, 21:30 ET The American Hotel Owners Charitable Association (AHOCA) Officially Launches Its Asia Chapter in Hong Kong, Creating a Unified Platform to Connect Industry Leaders in the US and Asia
Tsui, will bring together senior hotel owners, principals of family-backed hospitality groups, and industry leaders from United States, Hong Kong, Macau and the wider region for a closed-door dialogue on cross‑border collaboration, long‑term hotel ownership, and capital partnership opportunities.Founded
More news about: CSTS Enterprises
May 21, 2026, 17:35 ET Manulife Announces Executive Leadership Team Changes
appointed President & CEO, Manulife Canada, joining the Executive Leadership Team. Most recently serving as CEO, Manulife Hong Kong & Macau, Patrick has more than 25 years of leadership experience in the insurance and financial services industry, along with a track record of delivering results
More news about: Manulife Financial Corporation
May 21, 2026, 17:35 ET Manulife Announces Executive Leadership Team Changes
appointed President & CEO, Manulife Canada, joining the Executive Leadership Team. Most recently serving as CEO, Manulife Hong Kong & Macau, Patrick has more than 25 years of leadership experience in the insurance and financial services industry, along with a track record of delivering results
More news about: Manulife Financial Corporation
May 21, 2026, 09:00 ET K25.ai, Led by Tech Veteran Andy Cheung, Eyes Public Listing as World's First Prediction Market After $100M Valuation Investment from Nasdaq-Listed Strategic Partner
commercial development across Thailand, Singapore, Japan, Australia, New Zealand and other permitted APAC markets, excluding Mainland China, Hong Kong, Macau and other restricted jurisdictions.In connection with the strategic relationship, K25.ai's co-founders, including Mr. Andy Cheung, will join
More news about: K25.ai
May 21, 2026, 06:00 ET Innovent and HUTCHMED Jointly Announce NMPA Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma
radiation.Takeda holds the exclusive worldwide license to further develop, commercialize, and manufacture fruquintinib outside mainland China, Hong Kong and Macau, marketing it under the brand name FRUZAQLA®. Fruquintinib received approval for the treatment of previously treated metastatic colorectal
More news about: Innovent Biologics
May 20, 2026, 06:00 ET Baozun Announces First Quarter 2026 Unaudited Financial Results
digital marketing.b> BZI includes our e-commerce businesses outside of Chinese Mainland, including locations such as Hong Kong SAR, Macau SAR and Taiwan Region and South East Asia.(ii) Brand Management engages in holistic brand management, encompassing strategic
More news about: Baozun Inc.
May 19, 2026, 20:00 ET Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline
Asia Pacific markets. Its lead commercial asset, XPOVIO® (selinexor), is approved in the Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia, and has been included in the national insurance schemes in five of these
More news about: Antengene Corporation Limited
May 19, 2026, 04:57 ET 亞洲先鋒娛樂夥CountR現金管理 升級轉型「一站式」娛樂場服務
澳門和香港2026年5月19日 /美通社/ -- 港上市澳門公司亞洲先鋒娛樂控股有限公司（APE；8400.HK）宣布與德國 CountR GmbH 簽署分銷協議，這項合作緊接公司本月推出的 BEE MACAU —— 澳門首家啤牌廠開業，標誌 APE 正式由單一電子博彩設備供應商，躍升為整合電子博彩遊戲、娛樂場桌面遊戲配套及現金管理系統的「一站式」娛樂場解決方案提供商，將大幅提升營運的成本效益與業務靈活性。
More news about: 亞洲先鋒娛樂控股有限公司
May 18, 2026, 08:42 ET Tiger Group Sale Features Audiovisual Gear in Canada
Las Vegas, Nashville, Miami, Orlando, Pensacola, London, Birmingham, Manchester, Frankfurt, Calgary, Toronto, Montreal, Ottawa, Quebec City, Halifax, Macau, and Hong Kong.Media Contacts: At Tiger Commercial & Industrial Division, Jonathan Holiday, (805) 367-3893,
More news about: Tiger Group
May 18, 2026, 07:00 ET SU Group Launches Expanded AI Security Offering to Meet Surging Global Demand
solution designed to enhance the detection of dangerous goods and prohibited items. The partnership initially covers the territory of Hong Kong and Macau.With many years in the X-ray screening business and a well-established customer network, SU Group believes the introduction of Seetrue's technology
More news about: SU Group Holdings Limited
May 15, 2026, 13:52 ET Chow Tai Fook Unveils Its First Global Flagship Store in Hong Kong
Chow Tai Fook first global flagship store spanning around 10,000 square feet, it is the group's largest store in the Hong Kong and Macau market. The store features the Heritage Pavilion, celebrating Chow Tai Fook's journey and the artisanal heritage that
More news about: Chow Tai Fook
May 13, 2026, 21:00 ET GLN International Expands QR Payment Coverage Across Mainland China Through Weixin Pay Network
Mainland China, Japan, Thailand, the Philippines, Laos, Taiwan, Singapore, Hong Kong SAR, Macau, Guam, and Saipan, connecting users to more than 200 million QR merchants worldwide.
More news about: GLN International
May 12, 2026, 20:00 ET Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody
Kelun-Biotech exclusive rights to research, develop, manufacture and commercialize SKB118/CR-001 in Greater China (including Mainland China, Hong Kong, Macau, and Taiwan). In January 2026, Crescent announced the regulatory clearance of the IND application for SKB118/CR-001 by the U.S. Food and Drug Administration
More news about: Kelun-Biotech